[1] Sethi S, Murphy TF.Infection in the pathogenesis and course of chronic obstructive pulmonary disease[J]. N Engl JMed, 2008, 359(22):2355-2365. [2] Weitzenblum E, Hirth C, Ducolone A, et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease[J]. Thorax, 1981, 36(10):752-758. [3] Cooper R, Ghali J, Simmons BE, et al. Elevated pulmonary artery pressure.An independent predictor of mortali- ty[J]. Chest, 1991, 99(1):112-120. [4] 陶玉坚, 孙思庆, 林勇.低氧性肺动脉高压和肺血管结构重构以及葛根素的干预效应[J]. 中国临床康复, 2005, 9(23):150-152. [5] 李继武, 季亢挺, 范小芳, 等.葛根素对慢性低氧高二氧化碳大鼠肺动脉高压形成的预防作用[J]. 中国预防医学杂志, 2008, 9(2):35-38. [6] Zhu Z, Xu Y, Zou HJ, et al. Effects of puerarin on pulmonary vascular remodeling and protein kinase C-alpha in chronic cigarette smoke exposure smoke-exposed rats[J]. Huazhong Univ Sci Technolog Med Sci, 2008, 28(1):27-32. [7] 姚丹, 丁选胜.葛根素药理作用机制探讨及临床应用[J]. 中国临床药理学与治疗学杂志, 2008, 13(4):468-474. [8] Watanabe S, Yamakami J, Tsuchiya M, et al. Anti-inflammatory effect of theophylline in rats and its involvement of the glucocorticoid-glucocorticoid receptor sy stem[J]. J Pharmacol Sci, 2008, 106(4):566-570. [9] Löwenberg M, Stahn C, Hommes DW, et al. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands[J]. Steroids, 2008, 73(9 10):1025-1029. [10] Urbach V, Verriere V, Grumbach Y, et al. Rapid antisecretory effects of glucocorticoids in human airway epithelium[J]. Steroids, 2006, 71(4):323-328. |